Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study

  • Original Article
  • Published:
International Journal of Obesity Submit manuscript

Abstract

Objectives:

We aimed (1) to construct a modified PROCAM risk algorithm, which incorporates BMI/waist circumference in a model for predicting coronary events; (2) to evaluate how accurate this and the previously established PROCAM risk algorithm predict coronary risk in individuals with metabolic syndrome.

Design:

Prospective Cardiovascular Münster (PROCAM) Study, a prospective study of men and women at work in the northwest of Germany.

Subjects:

A total of 7134 men aged 35–65 years at study entry.

Measurements:

On the basis of 404 major coronary events (defined as nonfatal MI and coronary deaths), which occurred within 10 years of follow-up, a modified PROCAM risk algorithm was constructed by incorporating BMI/waist circumference as fixed variable in a Cox proportional hazards model for predicting coronary events. The metabolic syndrome was defined according to the latest recommendations proposed by the NCEP-ATP III Panel.

Results:

Men who were classified as having the metabolic syndrome (n=2325, prevalence: 32.6%) were 2.59-fold more likely to experience a major coronary event within 10 years of follow-up than men not having the metabolic syndrome. In men with metabolic syndrome, the observed major coronary event rate of 9.6% corresponded well with their estimated global risk according to the modified BMI-based PROCAM risk algorithm (10.2%). Comparative calculations performed with the previously published fully adjusted PROCAM algorithm yielded very similar results.

Conclusion:

Both PROCAM algorithms provide very accurate means to ascertain coronary risk in male patients with metabolic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M . Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27: 1610–1619.

    Article  Google Scholar 

  2. Flegal KM, Carroll MD, Ogden CL, Johnson CL . Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–1727.

    Article  Google Scholar 

  3. Ford ES . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769–1778.

    Article  Google Scholar 

  4. Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.

    Article  CAS  Google Scholar 

  5. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138–1145.

    Article  CAS  Google Scholar 

  6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  Google Scholar 

  7. Alberti KG, Zimmet P, Shaw J . The metabolic syndrome—a new worldwide definition. Lancet 2005; 366: 1059–1062.

    Article  Google Scholar 

  8. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007; 99: 541–548.

    Article  Google Scholar 

  9. Despres JP, Lemieux I . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.

    Article  CAS  Google Scholar 

  10. Assmann G, Cullen P, Schulte H . The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J 1998; 19: A2–A11.

    PubMed  Google Scholar 

  11. Cullen P, Schulte H, Assmann G . The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997; 96: 2128–2136.

    Article  CAS  Google Scholar 

  12. Assmann G, Cullen P, Schulte H . Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310–315.

    Article  Google Scholar 

  13. Assmann G, Schulte H . Results and conclusions of the Prospective Cardiovascular Münster (PROCAM) Study. In: Assmann G (ed). Lipid Metabolism Disorders and Coronary Heart Disease. MMV Medizin Verlag: München, 1993, pp 19–68.

    Google Scholar 

  14. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes 2001; 25: 1782–1788.

    Article  CAS  Google Scholar 

  15. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087–2094.

    Article  CAS  Google Scholar 

  16. Nakamura T, Tokunga K, Shimomura I, Nishida M, Yoshida S, Kotani K et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239–246.

    Article  CAS  Google Scholar 

  17. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643–1649.

    Article  CAS  Google Scholar 

  18. Nesto RW . The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med 2003; 4: S11–S18.

    PubMed  Google Scholar 

  19. Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119: 812–819.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leibniz-Institute of Arteriosclerosis Research, University of Münster, Münster, Germany

    G Assmann, H Schulte & U Seedorf

  2. Institute of Clinical Chemistry and Laboratory Medicine, University of Münster, Münster, Germany

    G Assmann

Authors
  1. G Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U Seedorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Assmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assmann, G., Schulte, H. & Seedorf, U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes 32 (Suppl 2), S11–S16 (2008). https://doi.org/10.1038/ijo.2008.29

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.29

  • Springer Nature Limited

Keywords

This article is cited by

Search

Navigation